Vaccinex Inc.

11/09/2019 | Press release | Distributed by Public on 11/09/2019 07:07

Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th[...]